StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Evaluating the Impact of an Immunisation Program of Meningococcal B Vaccine - Report Example

Cite this document
Summary
This report "Evaluating the Impact of an Immunisation Program of Meningococcal B Vaccine" discusses the strengths and limitations of the meningococcal B vaccine of basing the government's decision on the data sources. The report analyses the clinical places for the meningococcal B vaccine…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER94% of users find it useful

Extract of sample "Evaluating the Impact of an Immunisation Program of Meningococcal B Vaccine"

Report on Introduction and Evaluation of Meningococcal B Vaccine Student’s Name College Part 1 Task Description As a matter of fact, bacterial meningitis is caused by the bacteria Neisseria Meningitidis. In humans, six distinguishable serotypes exist that causes the pandemic disease namely: A, B, C, W135 and Y. Geographically, serotypes are distributed differently, where Africa is dominated by serotype A, while serotypes B and C are predominant in Australia, North America and Europe. Importantly, there are several vaccines for the disease that include conjugate and polysaccharide technologies. Available vaccines comprise of the tetravalent vaccine that offers protection against serogroups A, C, W135 and Y and monovalent vaccines for every serogroups A, B, and C. Many nations have effectively introduced meningococcal routine immunization programs, comprising of meningococcal C (for instance, Canada, UK, Australia) together with meningococcal A vaccine (for example, ‘meningitis belt nations of Africa’). Fortunately, Australia has recently licensed a new meningococcal B vaccine in the year 2013 together with many other nations. Meningococcal B is readily available for consumption in the Australian private market, but up to till now, it has never been integrated in the normal immunization programs. Introduction of a New National Meningococcal B Immunization Program My chosen country, Australia in this task which is a high income country, involves the consideration of whether the national government would include the meningococcal B vaccine within the government funded National Immunization Program. Clinical Place for Meningococcal B Vaccine Actually, invasive meningococcal B disease (IMD) turns to be an unusual illness that is brought about by the bacterium Neisseria meningitides (NCIRS, 2013). In 2011, the number of Australian cases reported added up to 184 (0.82 in every 100,000) and roughly 11 mortalities were recorded. Data that has been gathered between the years 1991 – 2011 reveals that occurrence is bimodal. In this scenario, the confirmed cases of Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(Evaluating the Impact of an Immunisation Program of Meningococcal B Report Example | Topics and Well Written Essays - 2750 words, n.d.)
Evaluating the Impact of an Immunisation Program of Meningococcal B Report Example | Topics and Well Written Essays - 2750 words. https://studentshare.org/health-sciences-medicine/2052781-report-evaluating-the-impact-of-an-immunisation-program
(Evaluating the Impact of an Immunisation Program of Meningococcal B Report Example | Topics and Well Written Essays - 2750 Words)
Evaluating the Impact of an Immunisation Program of Meningococcal B Report Example | Topics and Well Written Essays - 2750 Words. https://studentshare.org/health-sciences-medicine/2052781-report-evaluating-the-impact-of-an-immunisation-program.
“Evaluating the Impact of an Immunisation Program of Meningococcal B Report Example | Topics and Well Written Essays - 2750 Words”. https://studentshare.org/health-sciences-medicine/2052781-report-evaluating-the-impact-of-an-immunisation-program.
  • Cited: 0 times

CHECK THESE SAMPLES OF Evaluating the Impact of an Immunisation Program of Meningococcal B Vaccine

Neisseria meningitides or meningococcus

About 32% of meningococcal disease reported in the United States, and between 45% and >80% of meningococcal disease reported in Europe are due to MenB.... The vaccine described in this study acts against one serogroup of N.... Such antigens generally constitute the vaccine against the particular bacterium.... The five antigens identified were produced in a form that was suitable for large-scale production and made into vaccine form for human use by adding chemical compounds (adjuvants) that improve the immune response to vaccine antigens....
6 Pages (1500 words) Essay

Sources of Meningococcal Infection

This research paper 'Sources of meningococcal infection' is based broadly on the case study of a 19-year old student who was well, until the evening before admission to the A&E department, when he went to bed with a terrible headache.... What are the likely sources of meningococcal infection?... Briefly consider a more world-wide perspective of meningococcal disease.... page] An estimated 500,000 cases of meningococcal disease occur globally each year, with a mortality rate of about 10%....
14 Pages (3500 words) Essay

The Opinions About Vaccinating or Immunizations

(2012), this study discussed whether children with chronic diseases should receive the influenza vaccine.... And one of the most crucial findings of the study was the children who received almost no recommendation to get the influenza immunization vaccine had the lowest coverage (Pandolfi et al.... Despite the gravity and the seriousness of the influenza problem, the attitudes and beliefs about the vaccination program determine whether or not parents of children with chronic illnesses will receive the vaccine....
7 Pages (1750 words) Essay

Course assignement -

It is estimated that there are more than 60 million people worldwide who are currently refugees or internally displaced persons (UNHCR, 2007).... These people.... ... ... In many cases, life conditions in these settlements are not adequately healthy for long-term occupation.... Because of overcrowding, inadequate water/sanitation facilities and In addition, mass migration may lead to epidemics of communicable diseases particularly when populations residing in areas of low disease endemicity pass through or into areas of high endemicity during the course of their migration....
18 Pages (4500 words) Essay

Early Patient Contact

This course, Early Patient Contact, has been designed to give you the experience of communicating with "patients" at an early stage in your medical course at RCSI Bahrain.... It will give you an opportunity to learn more about the lives people lead, their worries, experiences.... ... ... ... The course may also introduce concepts of disease management, cultural and social aspects of illness and the importance of good communication....
30 Pages (7500 words) Essay

FDA Registration Of Neglected Tropical Disease Drugs And Its Impact On Developed Countries That Need

NTDs cause approximately 534,000 deaths each year (Sabin vaccine Institute).... This thesis "FDA Registration Of Neglected Tropical Disease Drugs And Its impact On Developed Countries " describes its impact on developed countries that need it; and its impact on the trust between the developed country drug agency and the indigenous patients....
34 Pages (8500 words) Thesis

National Immunization Technical Advisory Group: Meningococcal B immunization Program

This report "National Immunization Technical Advisory Group: meningococcal b immunization Program" offers recommendations regarding routine vaccination for people who are at increased risk for meningococcal disease.... Two types of meningococcal polysaccharide-protein conjugate vaccines offer protection against the serogroups of meningococcal A, C, Y, and W.... pidemiology of meningococcal Disease ... uring the period between the years 2005 and 2011, an estimation of 800 to 1,200 cases of meningococcal infection took place annually in the United States....
10 Pages (2500 words) Report

Implementing Rural Mobile Immunization Clinic

Observably, during the last quarter of 30 June 2015, an approximated percentage of 58 obtained full immunization in meningococcal C and dose 2 measles, mumps, and rubella (MMR).... meningococcal and dose 1 varicella should be administered at the ages of 12 months and 18 months respectively (Hull and McIntyre, 2006).... The provision of the government immunization services remains inaccessible, and if accessible then it marred with late commencement of the immunization program or maternal mental instability....
10 Pages (2500 words) Research Proposal
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us